EUVIMEDEUVIMED entdecken
Crossref

Histone deacetylases inhibitor Chidamide mitigates inflammation and insulin resistance by targeting VDR in skeletal muscle cells

Lulu Zhang, Maosen Zhang, Meng Zhu, Xinyu Luo, Longfei Cui, Yunfei Zhao, Jia-Mu Zhao

Molecular and Cellular Endocrinology · 2026-08 · 618 · 112801

DOI: 10.1016/j.mce.2026.112801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-08. Verfasst von Lulu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Insulin Resistance, Aminopyridines, Benzamides, Histone Deacetylase Inhibitors. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Tianjin Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of Type 2 diabetes mellitus (T2DM) is heavily driven by exacerbated insulin resistance and inflammation in skeletal muscle, a major site for insulin-stimulated glucose uptake. Therefore, targeting inflammation and insulin resistance within this tissue represents an effective therapeutic strategy for T2DM. While histone deacetylase inhibitors (HDACi) exhibit therapeutic potential for metabolic diseases, the specific impact of the novel HDACi, Chidamide, on regulating skeletal muscle insulin resistance remains to be elucidated. Here, we provide in vitro evidence that Chidamide mitigates skeletal muscle inflammation and insulin resistance in a palmitic acid (PA)-induced C2C12 cell model. We demonstrate that Chidamide alleviates inflammation and activates the Akt/GSK3β/AS160-mediated insulin signaling thereby promoting cell-surface localization of GLUT4 and glucose uptake. Mechanistically, PA downregulates the expression of the vitamin D receptor (VDR), contributing to the inflammatory response and impairing Akt/GSK3β/AS160-mediated insulin signaling, which ultimately inhibited GLUT4-mediated glucose uptake. Chidamide effectively alleviates these effects by upregulating VDR transcription, potentially through the augmentation of histone H3 acetylation, thereby restoring insulin sensitivity and increasing GLUT4-mediated glucose uptake. In conclusion, our findings provide a proof-of-concept for the potential utility of Chidamide as a therapeutic strategy to enhance skeletal muscle insulin sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceAminopyridinesBenzamidesHistone Deacetylase InhibitorsInflammationReceptors, CalcitriolMuscle, SkeletalAnimalsCell LineMiceProto-Oncogene Proteins c-aktSignal TransductionPalmitic AcidInsulinGlucoseGlucose Transporter Type 4Glycogen Synthase Kinase 3 betaGTPase-Activating Proteins

Stichwörter der Autor:innen

ChidamideInflammationInsulin resistanceSkeletal muscleVDR

Substanzen

AminopyridinesBenzamidesHistone Deacetylase InhibitorsReceptors, CalcitriolProto-Oncogene Proteins c-aktN-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamidePalmitic AcidInsulinGlucoseGlucose Transporter Type 4

Autor:innen und Institutionen

  • Tianjin Medical University, Tianjin, China.
  • Department of Nuclear Medicine, Tianjin Medical University General Hospital Airport Site, Tianjin, China. Electronic address: zhaoyunfei155@163.com.
  • Tianjin Medical University, Tianjin, China. Electronic address: JMZH0911@126.com.

Förderung

  • Tianjin Municipal Education Commission

Zitieren

APA

Zhang, L., Zhang, M., Zhu, M., Luo, X., Cui, L., Zhao, Y., & Zhao, J. M. (2026). Histone deacetylases inhibitor Chidamide mitigates inflammation and insulin resistance by targeting VDR in skeletal muscle cells. Molecular and Cellular Endocrinology, 618, 112801. https://doi.org/10.1016/j.mce.2026.112801

Vancouver

Zhang L, Zhang M, Zhu M, Luo X, Cui L, Zhao Y, et al. Histone deacetylases inhibitor Chidamide mitigates inflammation and insulin resistance by targeting VDR in skeletal muscle cells. Molecular and Cellular Endocrinology. 2026;618:112801. doi:10.1016/j.mce.2026.112801

BibTeX
@article{Zhang2026,
  author = {Zhang, Lulu and Zhang, Maosen and Zhu, Meng and Luo, Xinyu and Cui, Longfei and Zhao, Yunfei and Zhao, Jia-Mu},
  title = {Histone deacetylases inhibitor Chidamide mitigates inflammation and insulin resistance by targeting VDR in skeletal muscle cells},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  volume = {618},
  pages = {112801},
  doi = {10.1016/j.mce.2026.112801}
}
Kostenlos starten →